• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Molecular Evolution of Influenza A Viruses From Mauritius, 2017-2019

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2025 May;19(5):e70108.
doi: 10.1111/irv.70108. Molecular Evolution of Influenza A Viruses From Mauritius, 2017-2019

Magalutcheemee Ramuth[SUP] 1 2 [/SUP], Janaki Sonoo[SUP] 1 [/SUP], Fhooblall Mokshanand[SUP] 1 [/SUP], Belinda Herring[SUP] 3 [/SUP], Tessema Sofonias[SUP] 4 [/SUP], John McCauley[SUP] 5 [/SUP], Ashwamed Dinasing[SUP] 6 [/SUP], Florette K Treurnicht[SUP] 2 7 [/SUP]



Affiliations
Abstract

Background: Despite being a vaccine preventable disease, influenza remains a burden in African countries. In Mauritius, influenza virus activity is year-round but evidence-based data to guide vaccination and pandemic preparedness strategies are lacking. This study aimed to describe the genetic diversity of influenza A viruses detected in Mauritius between 2017 and 2019.
Methods: Influenza A/H1N1pdm09 and A/H3N2 virus isolates were sequenced using Oxford Nanopore technology. Sequence reads assembled by CZ ID and Genome Detective web-based tools were uploaded to the EpiFlu database of the Global Initiative on Sharing All Influenza Data (GISAID). Sequence alignments and phylogenetic analysis were performed using Nextclade and MEGA XI software. BioEdit software was used to view amino acid substitutions compared to annual vaccine strains. Prediction of potential N-linked glycosylation (PNG) sites was determined by NetNGlyc 1.0.
Results: Influenza A was predominant (92.6%), with A/H1N1pdm09 prevailing overall (62.5%) but A/H3N2 dominating in 2017 (55.9%). Phylogenetic analysis identified clade 6B dominance for A/H1N1pdm09, with notable substitutions E119K, Q136K and D151E linked to antigenic changes. A/H3N2 exhibited significant genetic diversity, with co-circulation of 3C.2a4 and 3C.2a1 in 2017 while 2018 predominant subclade 3C.2a1b.1 highlights continued antigenic drift. Loss of PNG sites at position 158 (11/21; 52.4%) in HA and position 329 (81.0%, 17/21) in NA of A/H3N2 viruses were observed.
Conclusions: Continued evolution of A/H1N1pdm09 and A/H3N2 viruses in Mauritius highlights the need for sustained genomic surveillance to inform vaccine and antiviral strategies. Data from Mauritius will contribute to understanding of influenza viruses' ecology in the African region and globally.

Keywords: Ct cycle threshold; GISAID Global Initiative on Sharing All Influenza Data; HA Haemagglutinin; ILI Influenza Like Illness; NA Neuraminidase; NGlyc N‐linked glycosylation; PCR Polymerase chain reaction; SARI Severe Acute Respiratory Illness.

 
Back
Top Bottom